Template:Abscess evidence overview/es - Revision history

Ostermayer at 05:38, 20 January 2026

2026-01-20T05:38:40Z

← Older revision		Revision as of 05:38, 20 January 2026
Line 1:		Line 1:
	<noinclude><languages/></noinclude>		<noinclude><languages/></noinclude>
	El Staphylococcus aureus resistente a la meticilina ([[Special:MyLanguage/MRSA\|MRSA]]) es una causa bien conocida de muchos abscesos en el servicio de urgencias siendo la causa más común de infecciones purulentas de piel y tejidos blandos.<ref>Maligner D et al. The prevalence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) in skin abscesses presenting to the pediatric emergency department. N C Med J. 2008 Sep-Oct;69(5):351-4.</ref><ref>Pickett A et al. Changing incidence of methicillin-resistant staphylococcus aureus skin abscesses in a pediatric emergency department. Pediatr Emerg Care. 2009 Dec;25(12):831-4.</ref><ref>Bradley W. Frazee et al. High Prevalence of Methicillin-Resistant Staphylococcus aureus in Emergency Department Skin and Soft Tissue Infections http://dx.doi.org/10.1016/j.annemergmed.2004.10.011</ref> El tratamiento para los abscesos cutáneos ha sido [[Special:MyLanguage/incision and drainage\|incisión y drenaje]] con antibióticos generalmente reservados para aquellos que también presentaban celulitis asociada. Este ensayo controlado aleatorizado multicéntrico, doble ciego de 5 servicios de urgencias de EE.UU. con >1200 pacientes desafía la doctrina tradicional de no usar antibióticos para abscesos simples pequeños no complicados que pueden ser drenados. Para abscesos de tamaño mediano, 2.5 x 2.0 x 1.5cm que se sometieron a I&D y coadministración de 5 días de [[Special:MyLanguage/TMP/SMX\|TMP/SMX]], las tasas de curación fueron 80.5% vs 73.6% con placebo e I&D.<ref>Talan DA et al.. "Trimethoprim–Sulfamethoxazole versus Placebo for Uncomplicated Skin Abscess". NEJM. 2016. 374(9):823-832. [EBQ:TMP-SMX vs Placebo for Uncomplicated Skin Abscess\|Bactrim and I&D NEJM]]</ref>		El Staphylococcus aureus resistente a la meticilina ([[Special:MyLanguage/MRSA\|MRSA]]) es una causa bien conocida de muchos abscesos en el servicio de urgencias siendo la causa más común de infecciones purulentas de piel y tejidos blandos.<ref>Maligner D et al. The prevalence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) in skin abscesses presenting to the pediatric emergency department. N C Med J. 2008 Sep-Oct;69(5):351-4.</ref><ref>Pickett A et al. Changing incidence of methicillin-resistant staphylococcus aureus skin abscesses in a pediatric emergency department. Pediatr Emerg Care. 2009 Dec;25(12):831-4.</ref><ref>Bradley W. Frazee et al. High Prevalence of Methicillin-Resistant Staphylococcus aureus in Emergency Department Skin and Soft Tissue Infections http://dx.doi.org/10.1016/j.annemergmed.2004.10.011</ref> El tratamiento para los abscesos cutáneos ha sido [[Special:MyLanguage/incision and drainage\|incisión y drenaje]] con antibióticos generalmente reservados para aquellos que también presentaban celulitis asociada. Este ensayo controlado aleatorizado multicéntrico, doble ciego de 5 servicios de urgencias de EE.UU. con >1200 pacientes desafía la doctrina tradicional de no usar antibióticos para abscesos simples pequeños no complicados que pueden ser drenados. Para abscesos de tamaño mediano, 2.5 x 2.0 x 1.5cm que se sometieron a I&D y coadministración de 5 días de [[Special:MyLanguage/TMP/SMX\|TMP/SMX]], las tasas de curación fueron 80.5% vs 73.6% con placebo e I&D.<ref>Talan DA et al.. "Trimethoprim–Sulfamethoxazole versus Placebo for Uncomplicated Skin Abscess". NEJM. 2016. 374(9):823-832. [EBQ:TMP-SMX vs Placebo for Uncomplicated Skin Abscess\|Bactrim and I&D NEJM]]</ref>

Ostermayer: Created page with " El Staphylococcus aureus resistente a la meticilina (MRSA) es una causa bien conocida de muchos abscesos en el servicio de urgencias siendo la causa más común de infecciones purulentas de piel y tejidos blandos.Maligner D et al. The prevalence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) in skin abscesses presenting to the pediatric emergency department. N C Med J. 2008 Sep-Oct;69(5):351-4.Pick..."

2026-01-20T05:34:28Z

Created page with " El Staphylococcus aureus resistente a la meticilina (MRSA) es una causa bien conocida de muchos abscesos en el servicio de urgencias siendo la causa más común de infecciones purulentas de piel y tejidos blandos.<ref>Maligner D et al. The prevalence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) in skin abscesses presenting to the pediatric emergency department. N C Med J. 2008 Sep-Oct;69(5):351-4.</ref><ref>Pick..."

← Older revision		Revision as of 05:34, 20 January 2026
Line 1:		Line 1:
	<noinclude><languages/></noinclude>		<noinclude><languages/></noinclude>
	~~<div lang="en" dir="ltr" class="mw-content-ltr">~~		El Staphylococcus aureus resistente a la meticilina ([[Special:MyLanguage/MRSA\|MRSA]]) es una causa bien conocida de muchos abscesos en el servicio de urgencias siendo la causa más común de infecciones purulentas de piel y tejidos blandos.<ref>Maligner D et al. The prevalence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) in skin abscesses presenting to the pediatric emergency department. N C Med J. 2008 Sep-Oct;69(5):351-4.</ref><ref>Pickett A et al. Changing incidence of methicillin-resistant staphylococcus aureus skin abscesses in a pediatric emergency department. Pediatr Emerg Care. 2009 Dec;25(12):831-4.</ref><ref>Bradley W. Frazee et al. High Prevalence of Methicillin-Resistant Staphylococcus aureus in Emergency Department Skin and Soft Tissue Infections http://dx.doi.org/10.1016/j.annemergmed.2004.10.011</ref> El tratamiento para los abscesos cutáneos ha sido [[Special:MyLanguage/incision and drainage\|incisión y drenaje]] con antibióticos generalmente reservados para aquellos que también presentaban celulitis asociada. Este ensayo controlado aleatorizado multicéntrico, doble ciego de 5 servicios de urgencias de EE.UU. con >1200 pacientes desafía la doctrina tradicional de no usar antibióticos para abscesos simples pequeños no complicados que pueden ser drenados. Para abscesos de tamaño mediano, 2.5 x 2.0 x 1.5cm que se sometieron a I&D y coadministración de 5 días de [[Special:MyLanguage/TMP/SMX\|TMP/SMX]], las tasas de curación fueron 80.5% vs 73.6% con placebo e I&D.<ref>Talan DA et al.. "Trimethoprim–Sulfamethoxazole versus Placebo for Uncomplicated Skin Abscess". NEJM. 2016. 374(9):823-832. [EBQ:TMP-SMX vs Placebo for Uncomplicated Skin Abscess\|Bactrim and I&D NEJM]]</ref>
	~~Methicillin-resistant~~ Staphylococcus aureus ([[Special:MyLanguage/MRSA\|MRSA]]) ~~is a well known cause of many abscesses in the ED being the most common cause of purulent skin and soft-tissue infections~~.<ref>Maligner D et al. The prevalence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) in skin abscesses presenting to the pediatric emergency department. N C Med J. 2008 Sep-Oct;69(5):351-4.</ref><ref>Pickett A et al. Changing incidence of methicillin-resistant staphylococcus aureus skin abscesses in a pediatric emergency department. Pediatr Emerg Care. 2009 Dec;25(12):831-4.</ref><ref>Bradley W. Frazee et al. High Prevalence of Methicillin-Resistant Staphylococcus aureus in Emergency Department Skin and Soft Tissue Infections http://dx.doi.org/10.1016/j.annemergmed.2004.10.011</ref> ~~Treatment for cutaneous abscesses has been~~ [[Special:MyLanguage/incision and drainage\|~~incision and drainage~~]] ~~with antibiotics generally reserved for those that also had associated cellulitis~~. ~~This multicenter, double-blind~~, ~~randomized Controlled Trial of~~ 5 ~~US EDs with~~ >1200 ~~patients challenges the traditional dogma of~~ no ~~antibiotics for simple small uncomplicated abscesses that can be drained~~. ~~For abscess of median size~~, 2.5 x 2.0 x 1.5cm ~~that underwent~~ I&D ~~and co-administration of~~ 5 ~~days of~~ [[Special:MyLanguage/TMP/SMX\|TMP/SMX]], ~~cure rates were~~ 80.5% vs 73.6% ~~with~~ placebo ~~and~~ I&D.<ref>Talan DA et al.. "Trimethoprim–Sulfamethoxazole versus Placebo for Uncomplicated Skin Abscess". NEJM. 2016. 374(9):823-832. [EBQ:TMP-SMX vs Placebo for Uncomplicated Skin Abscess\|Bactrim and I&D NEJM]]</ref>
	~~</div~~>

Ostermayer: Created page with "Template:Resumen de evidencia de absceso"

2026-01-20T05:32:16Z

Created page with "Template:Resumen de evidencia de absceso"

New page

<noinclude><languages/></noinclude>
<div lang="en" dir="ltr" class="mw-content-ltr">
Methicillin-resistant Staphylococcus aureus ([[Special:MyLanguage/MRSA|MRSA]]) is a well known cause of many abscesses in the ED being the most common cause of purulent skin and soft-tissue infections.<ref>Maligner D et al. The prevalence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) in skin abscesses presenting to the pediatric emergency department. N C Med J. 2008 Sep-Oct;69(5):351-4.</ref><ref>Pickett A et al. Changing incidence of methicillin-resistant staphylococcus aureus skin abscesses in a pediatric emergency department. Pediatr Emerg Care. 2009 Dec;25(12):831-4.</ref><ref>Bradley W. Frazee et al. High Prevalence of Methicillin-Resistant Staphylococcus aureus in Emergency Department Skin and Soft Tissue Infections http://dx.doi.org/10.1016/j.annemergmed.2004.10.011</ref> Treatment for cutaneous abscesses has been [[Special:MyLanguage/incision and drainage|incision and drainage]] with antibiotics generally reserved for those that also had associated cellulitis. This multicenter, double-blind, randomized Controlled Trial of 5 US EDs with >1200 patients challenges the traditional dogma of no antibiotics for simple small uncomplicated abscesses that can be drained. For abscess of median size, 2.5 x 2.0 x 1.5cm that underwent I&D and co-administration of 5 days of [[Special:MyLanguage/TMP/SMX|TMP/SMX]], cure rates were 80.5% vs 73.6% with placebo and I&D.<ref>Talan DA et al.. "Trimethoprim–Sulfamethoxazole versus Placebo for Uncomplicated Skin Abscess". NEJM. 2016. 374(9):823-832. [EBQ:TMP-SMX vs Placebo for Uncomplicated Skin Abscess|Bactrim and I&D NEJM]]</ref>
</div>